Window of opportunity for abatacept in RA-ILD. Early treated patients (<6 months vs >2 years) appear to do better
Tweet Content
Window of opportunity for abatacept in RA-ILD. Early treated patients (<6 months vs >2 years) appear to do better in terms of FVC. Abstr#2173 #ACR23 @RheumNow https://t.co/14IsA1KbAk https://t.co/ZbZEwzaOu0
Show on Archive Page
On
Display in Search Results
On
PDQ
Off